Rabl and Spadaro showed that the uncertainty of a health impact valuation study could be characterized using a lognormal distribution function with geometric standard deviation of 4. This implies that, if the central estimate is considered to be median
then the 95% confidence interval is between median divided by 16 and the median multiplied by 16